AMAG Pharmaceuticals Just Filed Its Quarterly Report: The components of b...


The components of basic and diluted net loss per share were as follows (in thousands, except per share data):

 

 

 

Three Months Ended March 31,

 

 

 

2014

 

2013

 

Net loss

 

$

(7,102

)

$

(3,895

)

Weighted average common shares outstanding

 

21,824

 

21,544

 

Net loss per share:

 

 

 

 

 

Basic and diluted

 

$

(0.33

)

$

(0.18

)

 

The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here.

To receive a free e-mail notification whenever AMAG Pharmaceuticals makes a similar move, sign up!

Other recent filings from the company include the following:

Amag Pharmaceuticals Provides Business Update And 2015 Financial Guidance - Jan. 12, 2015
AMAG: Other Events - Jan. 9, 2015
Major owner of AMAG Pharmaceuticals just disposed of 1,250,000 shares - Jan. 9, 2015
Amag Pharmaceuticals And Takeda Announce Mutual Termination Of Agreement To License, - Dec. 29, 2014

   Auto Refresh

Feedback